From NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders:

NeuroPhage Pharmaceuticals
NeuroPhage Pharmaceuticals

NeuroPhage Pharmaceuticals, a Cambridge, MA-based biotech startup focused on treating Alzheimer’s and other diseases thought to be caused by protein misfolding